-
Loading metrics
A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer’s disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial
- David S. Henry,
- Richard G. Pellegrino
x
- Published: October 18, 2023
- https://doi.org/10.1371/journal.pone.0292863